Proceeds from Equity Method Investment, Distribution, Return of Capital
Royalty Pharma Proceeds from Equity Method Investment, Distribution, Return of Capital increased by 747.1% to $42.31M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.7%, from $36.26M to $42.31M. Over 4 years (FY 2021 to FY 2025), Proceeds from Equity Method Investment, Distribution, Return of Capital shows an upward trend with a 276.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher inflows indicate successful performance or liquidity events within the company's portfolio of equity-method investments.
Detailed definition
Represents the cash inflows received from entities where the company holds a significant influence but not full control....
Peer comparison
Commonly reported by companies with complex joint venture structures or strategic minority stakes.
other_proceeds_from_equity_method_investment_dividends_o_21d9d4Historical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $130.75K | $130.75K | $130.75K | $0.00 | $0.00 | $0.00 | $0.00 | $34.77M | $0.00 | $4.46M | $4.66M | $4.97M | $3.94M | $11.49M | $3.24M | $36.26M | $62.99M | $905.00K | $4.99M | $42.31M |
| QoQ Change | — | +0.0% | +0.0% | -100.0% | — | — | — | — | -100.0% | — | +4.5% | +6.6% | -20.6% | +191.4% | -71.8% | >999% | +73.7% | -98.6% | +451.8% | +747.1% |
| YoY Change | — | — | — | — | -100.0% | -100.0% | -100.0% | — | — | — | — | -85.7% | — | +157.7% | -30.3% | +630.4% | >999% | -92.1% | +53.9% | +16.7% |
Proceeds from Equity Method Investment, Distribution, Return of Capital at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's proceeds from equity method investment, distribution, return of capital?
- Royalty Pharma (RPRX) reported proceeds from equity method investment, distribution, return of capital of $42.31M in Q1 2026.
- How has Royalty Pharma's proceeds from equity method investment, distribution, return of capital changed year-over-year?
- Royalty Pharma's proceeds from equity method investment, distribution, return of capital increased by 16.7% year-over-year, from $36.26M to $42.31M.
- What is the long-term trend for Royalty Pharma's proceeds from equity method investment, distribution, return of capital?
- Over 4 years (2021 to 2025), Royalty Pharma's proceeds from equity method investment, distribution, return of capital has grown at a 276.6% compound annual growth rate (CAGR), from $523.00K to $105.15M.
- What does proceeds from equity method investment, distribution, return of capital mean?
- Cash received from investments in associated companies or joint ventures.